Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Adding Inspra® (eplerenone) To Standard Therapy Reduces The Incidence Of New Onset Atrial Fibrillation/Flutter (AF/F) In Patients With Systolic Heart Failure, Sub-Analysis Shows
Yahoo/BusinessWire
Sunday, May 22, 2011 - 4:33pm
tags:
Inspra, atrial fibrillation, Pfizer
ShangPharma Reports 26% Increase in Q1 Revenues
Seeking Alpha
Sunday, May 22, 2011 - 4:32pm
tags:
ShangPharma, CROs
3 Low Beta Pharma Growth Stocks for Uncertain Times
Seeking Alpha
Sunday, May 22, 2011 - 4:31pm
tags:
Teva Pharmaceuticals, Questcor Pharmaceuticals, Emergent BioSolutions
The Next Big Thing In Biotech: ASCO Stocks (video)
The Street
Sunday, May 22, 2011 - 4:30pm
tags:
investors
Johnson & Johnson To Present Review of its Pharmaceutical Business
Galaxy Stocks
Saturday, May 21, 2011 - 11:53am
tags:
JNJ
Bruce Berkowitz Returns to Pharmaceuticals in Q1, Except Pfizer
Guru Focus
Saturday, May 21, 2011 - 11:50am
tags:
investors
Big Pharma's Golden Age Leads To Generics Windfall
NPR
Saturday, May 21, 2011 - 11:43am
tags:
generics
Angiotech Pharmaceuticals, Inc. will host a conference call discussing its financial results for the first quarter ended March 31, 2011
Genetic Engineering News
Saturday, May 21, 2011 - 11:42am
tags:
Angiotech, earnings
One Reason the Street Should Love Novo Nordisk's Earnings
Motley Fool
Saturday, May 21, 2011 - 11:17am
tags:
Novo Nordisk, earnings
J&J’s McNeil Unit Is Ordered to Pay $10 Million to Girl Injured by Motrin
Bloomberg
Saturday, May 21, 2011 - 11:16am
tags:
JNJ, McNeil, lawsuits, Motrin
Mylan Remains Neutral
Yahoo/Zacks
Saturday, May 21, 2011 - 11:15am
tags:
Mylan
Pfizer's Axitinib Encourages
Yahoo/Zacks
Saturday, May 21, 2011 - 11:14am
tags:
Pfizer, Axitinib, renal cell carcinoma
Sutent Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
Yahoo/BusinessWire
Saturday, May 21, 2011 - 11:11am
tags:
Sutent, neuroendocrine tumors, Pfizer
Novartis Adds New Drug Approvals In May
Investor's Business Daily
Saturday, May 21, 2011 - 11:10am
tags:
Novartis, Afinitor, neuroendocrine tumors
Abbott Hits a Triple
Motley Fool
Saturday, May 21, 2011 - 11:08am
tags:
Abbott Laboratories, TriLipix, cholesterol
J&J Puerto Rico Plant Has ‘Deeply Troubling’ Lack of Oversight
Bloomberg
Saturday, May 21, 2011 - 11:07am
tags:
JNJ
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Saturday, May 21, 2011 - 11:05am
tags:
Benlysta, Human Genome Sciences, Vibativ, Theravance, GSK, Victrelis, Merck, Xgeva, Amgen, Yervoy, Bristol-Myers Squibb, Fampyra, Acorda Therapeutics, Biogen Idec
Amgen Announces Voting Results Of Annual Meeting of Stockholders
Yahoo/PR NewsWire
Saturday, May 21, 2011 - 11:01am
tags:
Amgen
Targacept prices public offering for 3.7M shares
Yahoo/AP
Saturday, May 21, 2011 - 11:01am
tags:
Targacept, IPOs
Risk-Reward Balanced at Allos
Yahoo/Zacks
Saturday, May 21, 2011 - 11:00am
tags:
Allos

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.